Hollsteen
← F5

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $1.3B · 10-Q 0001048695-16-000026 filed Jan 27, 2016Equity incl. NCI · Q2 FY2016: $1.2B · 10-Q 0001048695-16-000035 filed Apr 27, 2016Equity incl. NCI · Q3 FY2016: $1.2B · 10-Q 0001048695-16-000041 filed Jul 27, 2016Equity incl. NCI · Q4 FY2016: $1.2B · 10-K 0001048695-16-000049 filed Nov 4, 2016Equity incl. NCI · Q1 FY2017: $1.2B · 10-Q 0001048695-17-000008 filed Feb 1, 2017Equity incl. NCI · Q2 FY2017: $1.2B · 10-Q 0001048695-17-000016 filed May 10, 2017Equity incl. NCI · Q3 FY2017: $1.2B · 10-Q 0001048695-17-000022 filed Aug 2, 2017Equity incl. NCI · Q4 FY2017: $1.2B · 10-K 0001048695-17-000028 filed Nov 3, 2017Equity incl. NCI · Q1 FY2018: $1.2B · 10-Q 0001048695-18-000005 filed Feb 2, 2018Equity incl. NCI · Q2 FY2018: $1.2B · 10-Q 0001048695-18-000017 filed May 2, 2018Equity incl. NCI · Q3 FY2018: $1.3B · 10-Q 0001048695-18-000025 filed Aug 1, 2018Equity incl. NCI · Q4 FY2018: $1.3B · 10-K 0001048695-18-000031 filed Nov 21, 2018Equity incl. NCI · Q1 FY2019: $1.4B · 10-Q 0001048695-19-000008 filed Feb 1, 2019Equity incl. NCI · Q2 FY2019: $1.5B · 10-Q 0001048695-19-000014 filed May 3, 2019Equity incl. NCI · Q3 FY2019: $1.6B · 10-Q 0001048695-19-000030 filed Aug 2, 2019Equity incl. NCI · Q4 FY2019: $1.8B · 10-K 0001048695-19-000034 filed Nov 15, 2019Equity incl. NCI · Q1 FY2020: $1.9B · 10-Q 0001048695-20-000012 filed Feb 5, 2020Equity incl. NCI · Q2 FY2020: $2.0B · 10-Q 0001048695-20-000027 filed May 6, 2020Equity incl. NCI · Q3 FY2020: $2.2B · 10-Q 0001048695-20-000035 filed Aug 5, 2020Equity incl. NCI · Q4 FY2020: $2.2B · 10-K 0001048695-20-000041 filed Nov 19, 2020Equity incl. NCI · Q1 FY2021: $2.4B · 10-Q 0001048695-21-000009 filed Feb 5, 2021Equity incl. NCI · Q2 FY2021: $2.0B · 10-Q 0001048695-21-000021 filed May 6, 2021Equity incl. NCI · Q3 FY2021: $2.2B · 10-Q 0001048695-21-000033 filed Aug 5, 2021Equity incl. NCI · Q4 FY2021: $2.4B · 10-K 0001048695-21-000044 filed Nov 16, 2021Equity incl. NCI · Q1 FY2022: $2.4B · 10-Q 0001048695-22-000007 filed Feb 4, 2022Equity incl. NCI · Q2 FY2022: $2.4B · 10-Q 0001048695-22-000015 filed May 6, 2022Equity incl. NCI · Q3 FY2022: $2.3B · 10-Q 0001048695-22-000025 filed Aug 5, 2022Equity incl. NCI · Q4 FY2022: $2.5B · 10-K 0001048695-22-000033 filed Nov 15, 2022Equity incl. NCI · Q1 FY2023: $2.6B · 10-Q 0001048695-23-000011 filed Feb 3, 2023Equity incl. NCI · Q2 FY2023: $2.7B · 10-Q 0001048695-23-000018 filed May 5, 2023Equity incl. NCI · Q3 FY2023: $2.7B · 10-Q 0001048695-23-000030 filed Aug 4, 2023Equity incl. NCI · Q4 FY2023: $2.8B · 10-K 0001048695-23-000039 filed Nov 14, 2023Equity incl. NCI · Q1 FY2024: $2.9B · 10-Q 0001048695-24-000012 filed Feb 5, 2024Equity incl. NCI · Q2 FY2024: $2.9B · 10-Q 0001048695-24-000079 filed May 6, 2024Equity incl. NCI · Q3 FY2024: $3.0B · 10-Q 0001048695-24-000125 filed Aug 6, 2024Equity incl. NCI · Q4 FY2024: $3.1B · 10-K 0001048695-24-000185 filed Nov 18, 2024Equity incl. NCI · Q1 FY2025: $3.2B · 10-Q 0001048695-25-000026 filed Feb 7, 2025Equity incl. NCI · Q2 FY2025: $3.3B · 10-Q 0001048695-25-000091 filed May 6, 2025Equity incl. NCI · Q3 FY2025: $3.5B · 10-Q 0001048695-25-000129 filed Aug 6, 2025Equity incl. NCI · Q4 FY2025: $3.6B · 10-K 0001048695-25-000157 filed Nov 25, 2025Equity incl. NCI · Q1 FY2026: $3.5B · 10-Q 0001048695-26-000023 filed Feb 5, 2026Equity incl. NCI · Q2 FY2026: $3.6B · 10-Q 0001048695-26-000051 filed May 5, 2026Equity incl. NCI · Q3 FY2026: $3.9B · 10-Q 0001048695-26-000067 filed Aug 6, 20261,1813,856Q1 FY2016Q3 FY2026
$MEquity incl. NCI · Q1 FY2016: $1.3B · 10-Q 0001048695-16-000026 filed Jan 27, 2016Equity incl. NCI · Q2 FY2016: $1.2B · 10-Q 0001048695-16-000035 filed Apr 27, 2016Equity incl. NCI · Q3 FY2016: $1.2B · 10-Q 0001048695-16-000041 filed Jul 27, 2016Equity incl. NCI · Q4 FY2016: $1.2B · 10-K 0001048695-16-000049 filed Nov 4, 2016Equity incl. NCI · Q1 FY2017: $1.2B · 10-Q 0001048695-17-000008 filed Feb 1, 2017Equity incl. NCI · Q2 FY2017: $1.2B · 10-Q 0001048695-17-000016 filed May 10, 2017Equity incl. NCI · Q3 FY2017: $1.2B · 10-Q 0001048695-17-000022 filed Aug 2, 2017Equity incl. NCI · Q4 FY2017: $1.2B · 10-K 0001048695-17-000028 filed Nov 3, 20171,1811,229Q1 FY2016Q4 FY2017
Q2 FY2016
1,181$M
All values (43)
PeriodValue ($M)Status
Q3 FY20263,856reported
Q2 FY20263,650reported
Q1 FY20263,538reported
Q4 FY20253,592reported
Q3 FY20253,472reported
Q2 FY20253,314reported
Q1 FY20253,236reported
Q4 FY20243,129reported
Q3 FY20243,011reported
Q2 FY20242,933reported
Q1 FY20242,861reported
Q4 FY20232,800reported
Q3 FY20232,658reported
Q2 FY20232,726reported
Q1 FY20232,582reported
Q4 FY20222,469reported
Q3 FY20222,323reported
Q2 FY20222,397reported
Q1 FY20222,405reported
Q4 FY20212,360reported
Q3 FY20212,192reported
Q2 FY20212,008reported
Q1 FY20212,402reported
Q4 FY20202,232reported
Q3 FY20202,154reported
Q2 FY20201,998reported
Q1 FY20201,929reported
Q4 FY20191,761reported
Q3 FY20191,624reported
Q2 FY20191,467reported
Q1 FY20191,409reported
Q4 FY20181,285reported
Q3 FY20181,266reported
Q2 FY20181,227reported
Q1 FY20181,227reported
Q4 FY20171,229reported
Q3 FY20171,205reported
Q2 FY20171,185reported
Q1 FY20171,195reported
Q4 FY20161,185reported
Q3 FY20161,187reported
Q2 FY20161,181reported
Q1 FY20161,263reported

CSV with all sources · Technical ID: equity_total

More metrics for F5

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$1.2B
Period
Q2 FY2016, ended Mar 31, 2016 · as of Mar 31, 2016 (balance as of date, not a sum)
Source
10-Q, filed Apr 27, 2016 · 0001048695-16-000035
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.2BApr 27, 201610-Q 0001048695-16-000035reported · confidence 1. · current